Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 551-556

  Caron, Joshua E ^a   Krull, Kevin R ^b   Hockenberry, Marilyn ^c   Jain, Neelam ^b   Kaemingk, Kris ^d   Moore, Ida M ^b  

^a Veteran's Association Medical Center   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d University of Arizona ^*

Author keywords

Leukemia; Neurocognitive; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; METHOTREXATE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ATTENTION DISTURBANCE; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBROSPINAL FLUID ANALYSIS; CHILD; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OXIDATIVE STRESS; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TASK PERFORMANCE; VERBAL BEHAVIOR; WORKING MEMORY; EMOTION; MEMORY; METABOLISM; PSYCHOLOGICAL ASPECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMOTIONS; FEMALE; HUMANS; MALE; MEMORY; METHOTREXATE; OXIDATIVE STRESS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; VERBAL BEHAVIOR;

EID: 69849108260     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22128     Document Type: Article

References (34)

1. Gurney JG, Bondy ML. Epidemiology of Childhood Cancer. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th edition. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2006. pp. 1-13.
2. Ries LAG, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999.
3. Dickerman JD. The late effects of childhood cancer therapy. Pediatrics 2007;119:554-568. (Pubitemid 46407553)
4. Jankovic M, Brouwers P, Valsecchi MG, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 1994;344:224-227.
5. Spiegler BJ, Kennedy K, Maze R, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006;24:3858-3864. (Pubitemid 46630732)
6. Waber DP, Turek J, Catania L, et al. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol 2007;25:4914-4921. (Pubitemid 350220422)
7. von der Weid N, Mosimann I, Hirt A, et al. Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: Age- and sex-related differences. Eur J Cancer 2003;39:359-365. (Pubitemid 36140054)
8. Carey ME, Hockenberry MJ, Moore IM, et al. Brief report: Effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol 2007;32:189-193.
9. Montour-Proulx I, Kuehn SM, Keene DL, et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol 2005;20:129-133. (Pubitemid 40484853)
10. Reddick WE, Glass JO, Helton KJ, et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. Am J Neuroradiol 2005;26:1263-1269. (Pubitemid 43821984)
11. Carey ME, Haut MW, Reminger SL, et al. Reduced frontal white matter volume in long-term childhood leukemia survivors: A voxel-based morphometry study. Am J Neuroradiol 2008;29:792-797.
12. Stuss DT, Alexander MP, Benson DF. Frontal lobe functions. In: Trimle MR, Cummings JL, editors. Contemporary behavioral neurology. Boston: Butterworth-Heinemann; 1997. pp. 169-187.
13. Lamar M, Zonderman AB, Resnick S. Contribution of specific cognitive processes to executive functioning in an aging population. Neuropsychology 2002;16:156-162. (Pubitemid 34280250)
14. Moore IM, Espy KA, Kaufmann P, et al. Cognitive consequences and central nervous system injury following treatment for childhood leukemia. Semin Oncol Nurs 2000;16:279-290; discussion 291-1279
15. Miketova P, Kaemingk K, Hockenberry M, et al. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia. Biol Res Nurs 2005;6:187-195. (Pubitemid 43920964)
16. Babiak RM, Campello AP, Carnieri EG, et al. Methotrexate: Pentose cycle and oxidative stress. Cell Biochem Funct 1998;16:283-293.
17. Jahovic N, Cevik H, Sehirli AO, et al. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 2003;34:282-287. (Pubitemid 36469775)
18. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998;39:1529-1542.
19. Farooqui AA, Horrocks LA. Lipid peroxides in the free radical pathophysiology of brain diseases. Cell Mol Neurobiol 1998;18:599-608. (Pubitemid 29012939)
20. Moore IM, Miketova P, Hockenberry M, et al. Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia. Biol Res Nurs 2008;9:311-319.
21. Gioia GA, Isquith PK, Guy SC, et al. Behavior rating inventory of executive function. Odessa, FL: Psychological Assessment Resources, Inc.; 2000.
22. Reynolds CR, Kamphaus RW. Behavior assessment system for children - Manual. Circle Pine, MN: American Guidance Service, Inc.; 1992.
23. Korkman M, Kirk U, Kemp S. NEPSY: A developmental neuropsychological assessment. San Antonio: Harcourt Assessment, Inc.; 2001.
24. Hockenberry M, Krull K, Moore K, et al. Longitudinal evaluation of fine motor skills in children with leukemia. J Pediatr Hematol Oncol 2007;29:535-539. (Pubitemid 47356807)
25. Espy KA, Moore IM, Kaufmann PM, et al. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: A prospective study. J Pediatr Psychol 2001;26:1-9.
26. Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev 2006;12:174-183. (Pubitemid 44646326)
27. Moore BD III. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 2005;30:51-63. (Pubitemid 40041441)
28. Nathan PC, Patel SK, Dilley K, et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: A report from the Children's Oncology Group. Arch Pediatr Adolesc Med 2007;161:798-806. (Pubitemid 47236448)
29. Bongarzone ER, Pasquini JM, Soto EF. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J Neurosci Res 1995;41:213-221.
30. Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 2003;23:263-274.
31. Gerstner B, DeSilva TM, Genz K, et al. Hyperoxia causes maturation-dependent cell death in the developing white matter. J Neurosci 2008;28:1236-1245. (Pubitemid 351186357)
32. Wilke M, Krageloh-Mann I, Holland SK. Global and local development of gray and white matter volume in normal children and adolescents. Exp Brain Res 2007;178:296-307. (Pubitemid 46440574)
33. Brocki KC, Bohlin G. Executive functions in children aged 6 to 13: A dimensional and developmental study. Dev Neuropsychol 2004;26:571-593. (Pubitemid 39314808)
34. Matute E, Rosselli M, Ardila A, et al. Verbal and nonverbal fluency in Spanish-speaking children. Dev Neuropsychol 2004;26:647-660. (Pubitemid 39314812)